TATA Health International Holdings Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was HKD 144.61 million compared to HKD 160.93 million a year ago. Net income was HKD 9.61 million compared to net loss of HKD 60.76 million a year ago.

Basic earnings per share from continuing operations was HKD 0.04 compared to basic loss per share from continuing operations of HKD 0.26 a year ago.